Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies
Rare diseases affect over 300 million people worldwide and pose unique research challenges. In silico approaches, such as mechanistic models, machine learning, and simulations, offer scalable tools for disease characterisation, drug discovery, and virtual…
Continue Reading
